Vivos Therapeutics VVOS
NASDAQ VVOS
$0.17 -0.01 (-5.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vivos Therapeutics (VVOS) Net Income towards Common Stockholders (QoQ) (2020 - 2026)

Analysis

Vivos Therapeutics (VVOS) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Align Technology 11.30 Bn 10.20 Bn 757.43 Mn
2 Envista Holdings 4.38 Bn 3.26 Bn 407.00 Mn
3 Dentsply Sirona 2.27 Bn 2.03 Bn 493.00 Mn
4 Milestone Scientific 37.81 Mn 35.20 Mn 1.56 Mn
5 Dror Ortho-Design 9.77 Mn 9.68 Mn -
6 Vivos Therapeutics 2.76 Mn 790,007.20 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.65%
Mar 31, 2026 -10.47%
Dec 31, 2025 -28.78%
Sep 30, 2025 -7.72%
Jun 30, 2025 -29.74%
Mar 31, 2025 -33.93%
Dec 31, 2024 -10.28%
Sep 30, 2024 -35.54%
Jun 30, 2024 48.71%
Mar 31, 2024 12.53%
Dec 31, 2023 -105.54%
Sep 30, 2023 62.14%
Jun 30, 2023 -224.60%
Mar 31, 2023 72.03%
Dec 31, 2022 -12.05%
Sep 30, 2022 22.28%
Jun 30, 2022 -31.16%
Mar 31, 2022 27.89%
Dec 31, 2021 -35.58%
Sep 30, 2021 -34.88%